COA/ICORS2019: Perioperative IA-IV TXA most effective regimen for reducing blood loss in TKA .
Combined Intra-articular and Intravenous Tranexamic Acid Administration Associated with Improved Early Rehabilitation Outcomes after Total Knee Arthroplasty : A Randomised Controlled Trial
179 patients scheduled for total knee arthroplasty were randomized to one of three tranexamic acid (TXA) administration groups: one group received intraarticular TXA combined with pre- and postoperative intravenous (IV) TXA; one group received intraarticular TXA combined with just preoperative IV TXA; and one group received intraarticular TXA alone. Significant differences between groups in favour of the group which was administered intraarticular TXA was observed in hemoglobin drop after 2 days, range of knee extension at 6 months, and Knee Society Score at 6 months.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
